In this article, Lt. Col. Rakesh Jetly, a psychiatrist and senior health adviser for the Canadian Forces, said the department of national defence (DND) is committed to evidence-based care, and would embrace any treatment that has undergone rigorous scientific research to help relieve suffering of battle-scarred troops. "If you replaced Ecstasy with substance X - whether it was an absolutely approved legal drug, a mainstream medication, my answer would be the same. The fact that it's Ecstasy means nothing to us," Jetly told QMI Agency. "If there's any substance, any drug that has the research, the randomized controlled studies, the publications to prove its efficacy, we would entertain adding it as an approved treatment."

This article discusses a recent study on the potential of ketamine to help people suffering from bipolar disorder.

This is a brief article that discusses the effects of the MDMA-PTSD pilot study.

This article discusses the potential role of psilocybin in helping a variety of health issues. It also discusses the new study at New York University examining the effectiveness of psilocybin in helping the terminally ill.

This article discusses the recent MDMA-PTSD pilot study and mentions the new veteran study.